ChemicalBook >> CAS DataBase List >>Leptomycin B

Leptomycin B

CAS No.
87081-35-4
Chemical Name:
Leptomycin B
Synonyms
Lepomycin B;Leprimycin B;LEPTOMYCIN B;antibioticci940;antibioticcl1957a;Leptomycin B solutio;Leptomycin B (CI 940;Leptomycin B (0.2mg/ml);LeptoMycin B 1% soluton;InSolution? Leptomycin B,
CBNumber:
CB9500811
Molecular Formula:
C33H48O6
Molecular Weight:
540.73
MDL Number:
MFCD06795848
MOL File:
87081-35-4.mol
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-07-16 07:06:08

Leptomycin B Properties

Melting point 41-44°, with prior softening (Hokanson)
alpha D -24.5° (c = 0.70 in MeOH); D23 -157 ° (c = 0.7% in chloroform)
Boiling point 725.8±60.0 °C(Predicted)
Density 1.072±0.06 g/cm3(Predicted)
Flash point 11°(52°F)
storage temp. −20°C
solubility Supplied in solution in ethanol (1 mg/ml). Further dilutions may be made with either ethanol or DMSO.
pka 5.10±0.33(Predicted)
form Liquid
color White to off-white
Stability Stable for 1 year from date of purchase as supplied. Solutions or dilutions in DMSO are not stable. Solutions should be made fresh and used within one working day.
InChIKey YACHGFWEQXFSBS-XYERBDPFSA-N
SMILES C(O)(=O)/C=C(\C)/C[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)/C=C(\C)/C=C/C[C@@H](C)/C=C(/CC)\C=C\[C@@H]1OC(=O)C=C[C@@H]1C
FDA UNII Y031I2N1EO
UNSPSC Code 12352200
NACRES NA.77

SAFETY

Risk and Safety Statements

Symbol(GHS)  Flame (GHS02)Skull and Crossbones (GHS06)Health Hazard (GHS08)
GHS02,GHS06,GHS08
Signal word  Danger
Hazard statements  H225-H301+H311+H331-H370
Precautionary statements  P210-P280-P301+P310+P330-P302+P352+P312-P304+P340+P311
Hazard Codes  F,T
Risk Statements  23/25-36/38-39/23/24/25-23/24/25-11
Safety Statements  7-16-24-33-45-36/37
RIDADR  UN 1230 3/PG 2
WGK Germany  3
HazardClass  3
HS Code  29419090
Storage Class 3 - Flammable liquids
Hazard Classifications Eye Irrit. 2
Flam. Liq. 2
NFPA 704
3
0 0

Leptomycin B price More Price(58)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich L2913 Leptomycin B solution from Streptomyces sp. ≥95% (HPLC), Supplied in methanol: water (7:3) 87081-35-4 0.5μg $63.6 2026-04-30 Buy
Sigma-Aldrich L2913 Leptomycin B solution from Streptomyces sp. ≥95% (HPLC), Supplied in methanol: water (7:3) 87081-35-4 2x0.5μg $118 2026-04-30 Buy
Sigma-Aldrich L2913 Leptomycin B solution from Streptomyces sp. ≥95% (HPLC), Supplied in methanol: water (7:3) 87081-35-4 5x0.5μg $259 2026-04-30 Buy
Sigma-Aldrich L2913 Leptomycin B solution from Streptomyces sp. ≥95% (HPLC), Supplied in methanol: water (7:3) 87081-35-4 10x0.5μg $405 2026-04-30 Buy
Sigma-Aldrich L2913 Leptomycin B solution from Streptomyces sp. ≥95% (HPLC), Supplied in methanol: water (7:3) 87081-35-4 5μg $439 2026-04-30 Buy
Product number Packaging Price Buy
L2913 0.5μg $63.6 Buy
L2913 2x0.5μg $118 Buy
L2913 5x0.5μg $259 Buy
L2913 10x0.5μg $405 Buy
L2913 5μg $439 Buy

Leptomycin B Chemical Properties, Uses, Production

Description

Leptomycin B (87081-35-4) is an inhibitor of nuclear export of proteins. Acts via covalent binding to and inhibiting CRM1/exportin-1.1 Inhibits the nuclear export of the HIV regulatory protein Rev.2 Leptomycin B stabilizes p53 by blocking its nuclear export.3

Uses

Leptomycin B is the dominant and most studied member of the leptomycin class, isolated from selected Streptomyces strains. Leptomycin B is a nanomolar active and specific nuclear export inhibitor. Its target is CRM1/exportin1, a protein in the nuclear export sequence (NES). Proteins affected include c-Abl, cyclin B1, HIV-1 Rev, IκB, MPF, MAP/ERK, MDM2/p53, NF-κB/IκB7 and PKA. Leptomycin B inhibits export of many RNAs, e.g. COX-2 and c-FOS mRNA. Leptomycin B also shows antifungal and antibacterial and potent antitumour activities.

Uses

Biological tool for studying nuclear localization and protein trafficking in eukaryotic cells.

Uses

Potent, specific inhibitor of nuclear export signal (NES)-dependent protein export from the nucleus

Definition

ChEBI: A leptomycin having a (2E,10E,12E,16Z,18E)-double bond configuration as well as an ethyl substituent at position 17.

Biological Functions

Leptomycin B (LMB) is an unsaturated, branched-chain fatty acid that proved a potent tool in nuclear export studies. It was isolated from Streptomyces sp. strain ATS 1287. Until recently, LMB has been the only known small-molecule inhibitor of nuclear transport. The nuclear export inhibitor leptomycin B (LMB) prevents the export of proteins from the nucleus to the cytoplasm, protects p53 from Mdm2-mediated degradation, and potent inducer of p53 transcriptional activity. It is a specific inhibitor of the nuclear export of proteins containing leucine-rich nuclear export signal (NES). Supplementing sub-nanomolar concentrations of LMB to cultured cells caused inhibition of nuclear export of leucine-rich NES-bearing protein. Since its discovery as a potent inhibitor of nuclear export, a large number of shuttling proteins, performing a diverse range of cellular functions, are now known to accumulate in the nucleus.

General Description

Leptomycin B is an anti-fungal antibiotic, anti-tumor cytotoxin that inhibits CRM1-dependent, NES-dependent nucleo-cytoplasmic translocation (nuclear export inhibitor). NES containing proteins include HIV-1 REV; actin, c-Abl, cyclin B1, MDM2/p53, IB, MPF, PKA and MEK.

Biological Activity

Antifungal antibiotic that is an inhibitor of the nuclear export of proteins; acts by binding directly to and inhibiting CRM1/exportin-1. Inhibits the nuclear export of the HIV regulatory protein Rev and stabilizes p53. Antitumor in vitro and in vivo .

Biochem/physiol Actions

Leptomycin B is an unsaturated, branched-chain fatty acid, and is an important tool in the study of nuclear export. Leptomycin B is a specific inhibitor of proteins containing nuclear export signal. Leptomycin B inhibits nucleo-cytoplasmic translocation of molecules such as the HIV-1 Rev protein and Rev-dependent export of mRNA. The addition of very small amounts to fibroblasts causes accumulation of MEK in the nucleus. Other proteins that are influenced by leptomycinB are actin, c-Abl, cyclin B1, MDM2/p53, IκB, MPF, and PKA. The suggested inhibition mechanism involves the direct binding of leptomycinB to CRM1, which blocks the binding of CRM1 to proteins containing the nuclear export signal, via the interaction with cysteine residue in CRM1 control conserved region.

Mechanism of action

The nuclear export inhibition mechanism involves the direct binding of Leptomycin B to exportin1, which blocks the binding of exportin1 to proteins containing the leucine-rich NES. Later, NES-exportin1 interaction was identified on a conserved region near cysteine-529 residue of human exportin1. This cysteine-529 residue on exportin1 provides LMB sensitivity because unsaturated γ-lactone in LMB undergoes a Michael-type reaction by the sulfhydryl group on cysteine residue. Once LMB is bound to exportin1, the NES-bearing nuclear export cargo fails to bind the receptor.

storage

-20°C

Background

Leptomycin B, originally discovered and utilized as a potent anti-fungal antibiotic from Streptomyces sp., has more recently been identified to inhibit nuclear export of proteins and RNA containing a Nuclear Export Sequence. The mechanism behind LMB's potent inhibition is achieved by specifically binding to chromosomal region maintenance/exportin 1 protein; CRM1 binds to ribonuclear proteins containing the NES. LMB has also been reported to inhibit the degradation and subsequently lead to accumulation of p53 within the nucleus and has demonstrated specific anti-tumor properties, although toxic, at high doses.

References

[1] NOBUAKI KUDO . Leptomycin B Inhibition of Signal-Mediated Nuclear Export by Direct Binding to CRM1[J]. Experimental cell research, 1998, 242 2: Pages 540-547. DOI:10.1006/excr.1998.4136
[2] B WOLFF  Y W  J J Sanglier. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA.[J]. Chemistry & biology, 1997, 4 2: 139-147. DOI:10.1016/s1074-5521(97)90257-x
[3] D A FREEDMAN  A J L. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6.[J]. Molecular and Cellular Biology, 1998, 18 12: 7288-7293. DOI:10.1128/mcb.18.12.7288

217640-04-5
87081-35-4
Synthesis of Leptomycin B from 4-Pentyn-2-ol, 3-methyl-1-(phenylmethoxy)-, (2R,3S)-

Leptomycin B Preparation Products And Raw materials

Raw materials

Preparation Products

Leptomycin B Suppliers

Global Suppliers ( 175)
Supplier Tel Email Country ProdList Advantage
Shanghai Degayuan Biotechnology Co., Ltd 18301711315 18301711315 851746237@qq.com China 245 58
Wuhan SynBioLily Biotechnology Co.,Ltd. 18971458902 yangsong@synbiolily.com China 482 58
J & K SCIENTIFIC LTD. 18210857532 18210857532 jkinfo@jkchemical.com China 96815 76
3B Pharmachem (Wuhan) International Co.,Ltd. 18930552037 3bsc@sina.com China 15813 69
Chembest Research Laboratories Limited 021-20908456 sales@BioChemBest.com China 5996 61
Beijing HwrkChemical Technology Co., Ltd 89508211 18501085097 sales.bj@hwrkchemical.com China 9407 55
T&W GROUP 021-61551611 13296011611 contact@trustwe.com China 9884 58
Shanghai Aladdin Bio-Chem Technology Co.,LTD 400-6206333 13167063860 anhua.mao@aladdin-e.com China 29977 65
Shanghai Witofly Chemical Co.,Ltd sales@witofly.com China 2853 52
Guangzhou Isun Pharmaceutical Co., Ltd 020-39119399 18927568969 isunpharm@qq.com China 4773 55

View Latest Price from Leptomycin B manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Leptomycin B pictures 2026-07-15 Leptomycin B
87081-35-4
$213.00-652.00 99.71% 10g TargetMol Chemicals Inc.
LEPTOMYCIN B FROM STREPTOMYCES SP pictures 2019-12-26 LEPTOMYCIN B FROM STREPTOMYCES SP
87081-35-4
$1.00 1g ≥98% Career Henan Chemical Co
  • Leptomycin B pictures
  • Leptomycin B
    87081-35-4
  • $213.00-652.00
  • 99.71%
  • TargetMol Chemicals Inc.
Leptomycin B (CI 940 InSolution Leptomycin B, Streptomyces sp. - CAS 87081-35-4 - Calbiochem (2E,10Z,12E,16Z,18E)-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-19-(3-methyl-6-oxo-2,3-dihydropyran-2-yl)-8-oxo-nonadeca-2,10,12,16,18-pentaenoic acid 2,10,12,16,18-Nonadecapentaenoic acid, 19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-8-oxo- 2,10,12,16,18-Nonadecapentanoic acid, 19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-8-oxo- (2E,5S,6R,7S,9R,10E,12E,15R,16Z,18E)-19-[(2S,3S)-3,6-Dihydro-3-methyl-6-oxo-2H-pyran-2-yl]-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-8-oxo-2,10,12,16,18-nonadecapentaenoicacid LeptoMycin B( CI 940, LMB) antibioticcl1957a CI-940, Elactocin, PD 114720, ATS 1287B, Mantuamycin, 19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-8-oxo-2,10,12,16,18-Nonadecapentaenoic acid Elactocin, ATS 1287B, CI 940, CL 1957A, PD 114720, MantuaMycin 2,10,12,16,18-Nonadecapentaenoicacid,19-[(2S,3S)-3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl]-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-8-oxo-,(2E,5S,6R,7S,9R,10E,12E,15R,16Z,18E)- NSC 364372 CL 1957A Leptomycin B Antibiotic CI 940 Antibiotic CL 1957A Leptomycin B solution from Streptomyces sp. InSolution? Leptomycin B, Leptomycin B (0.2mg/ml) LeptoMycin B 1% soluton LEPTOMYCIN B FROM STREPTOMYCES SP 2,10,12,16,18-nonadecapentanoicacid,19-(3,6-dihydro-3-methyl-6-oxo-2h-pyran-2 7,9,11,15-hexamethyl-8-oxo--yl)-17-ethyl-6-hydroxy-5 antibioticci940 Leptomycin B (5 μg/mL in Ethanol) Leptomycin B solutio LEPTOMYCIN B FROM STREPTOMYCES SP USP/EP/BP XPO1,Chromosomal Maintenance 1,Fungal,inhibit,CI-940,EMT,Antibiotic,Leptomycin B,p53,nuclear export,mutation,EGFR,NSCLC,resistance,Inhibitor,CRM1,CI940,cancer,Exportin 1,KRAS Lepomycin B Leprimycin B LEPTOMYCIN B (2E,5S,6R,7S,9R,10E,12E,15R,16Z,18E)-17-Ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-19-((2S,3S)-3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)-8-oxononadeca-2,10,12,16,18-pentaenoic acid Leptomycin B (ethanol solution), Antibiotic, antifungal. Inhibitor of CRM-1 mediated nuclear export. Leptomycin B, 10 mM in DMSO Leptomycin B, Streptomyces sp. Leptomycin B solution from Streptomyces sp. 87081-35-4 C33H48O6 antibiotic Antifungal